Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. OWC Pharmaceutical Research Corp. (OWCP) Message Board

Re: your comment- "If I am mistaken and Ziv was sl

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 15624
(Total Views: 344)
Posted On: 04/19/2017 10:12:13 PM
Posted By: BruceLake
Re: HumanBeing #7525
Re: your comment- "If I am mistaken and Ziv was slated 10,000,000 options in this latest 10K please correct me."

On page 66 of the 10-K, re: Ziv Turner. I am assuming that #3 "Former Managing Director of the subsidiary" refers to Ziv Turner. Am I mistaken here in making this assumption? However, at the bottom of this list it states: "All 5 officers are serving in the Company and subsidiary since 2014". Was Ziv Turner with the company in 2014 and perhaps promoted in 2016?

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (cont.)

NOTE 13 - RELATED PARTY TRANSACTIONS

1. Chairmen and CEO of both parent and subsidiary, serves as employee of the subsidiary with compensation of $3,000 per month. In addition, he was awarded 10,000,000 options through the 2016 ESOP which vest over two years.

2. CFO of both parent and subsidiary receives compensation of $3,000 per month. In addition, he was awarded 750,000 options through the 2016 ESOP which vest over two years.

3. Former Managing Director of the subsidiary, received compensation of $3,000 per month. In addition, he was awarded 10,000,000 options through the 2016 ESOP which vest over two years

4. Chief Science Officer and Director of Research and Regulatory Affairs, receives compensation of $3,000 per month. In addition, he was awarded 7,000,000 options through the 2016 ESOP which vest over two years

5. COO and Interim CEO of subsidiary, receives compensation of $3,000 per month. In addition, he was awarded 7,000,000 options through the 2016 ESOP which vest over two years.

All 5 officers are serving in the Company and subsidiary since 2014. All are entitled to receive 60 days early notification of ending working relation and employee rights according to Israeli law, including severance pay.


(1)
(0)




OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us